Gene Therapy to Reverse Heart Failure Ready for Clinical Trials; Therapeutic Effectiveness and Safety of 'Next Great Thing in Heart Failure' Demonstrated, Thomas Jefferson University Study

Published: Jul 21, 2011

A promising gene therapy developed, in part, at Thomas Jefferson University's Center for Translational Medicine to prevent and reverse congestive heart failure is on the verge of clinical trials, after years of proving itself highly effective in the lab and a large animal study. Reporting in the online July 20 issue of Science Translational Medicine, cardiology researchers have demonstrated feasibility, the long-term therapeutic effectiveness and the safety of S100A1 gene therapy in a large animal model of heart failure under conditions approximating a clinical setting.

Back to news